
It is a type of cancer known as invasive ductal carcinoma that develops when aberrant cells that are growing in the milk duct lining transform and spread to the breast tissue outside the duct walls.
Timely treatment of Invasive Ductal Carcinoma is vital for many possible reasons:
Possible signs of invasive ductal carcinoma
The exact causes of IDC are not fully recognised, but several factors are involved to its development:
Risk Factors
With the use of individualized treatments like gene/protein inhibitors and advanced surgical methods like intraoperative margin assessment and targeted intraoperative radiation (TARGIT-IORT), the treatment of invasive ductal carcinoma (IDC) has advanced in Malaysia. Additionally, predictive models are being created to aid in directing treatment choices. These developments are intended to improve patient outcomes, lower recurrence rates, and increase therapy precision.
Adopting good lifestyle practices and taking charge of your health is key to preventing invasive ductal carcinoma (IDC); here are some tips-
Lumpectomy: It is the removal of a small margin of the surrounding tissue of the breast. It is also known as breast-conserving surgery. A lumpectomy may be followed by radiation treatments to treat any residual cancer cells.
Mastectomy: It is the removal of the entire breast. Mastectomy is a treatment for patients with multiple, very aggressive, or large invasive ductal tumours in most advanced cases.
Cost Start From USD 3000 - USD 10000Explore Options
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy.
Chemotherapy : Chemotherapy for breast cancer uses high-dose medications to kill cancer cells. You may receive chemo through veins or as a pill. Chemotherapy makes cancer cells smaller so that surgery can remove them more easily. It can be your primary treatment if you have stage 4 (metastatic) invasive ductal carcinoma.
Cost Start From USD 1500 - USD 3500Explore Options
Immunotherapy : Healthcare Providers may combine immunotherapy and chemotherapy to shrink the size of tumors before surgery. It also boosts your immune system to discover and destroy dangerous cancer cells.
Cost Start From USD 15000 - USD 50000Explore Options
Targeted Therapy : Treatments targeting genetic changes or malignant cells may be combined with immunotherapy and chemotherapy.
Cost Start From USD 2000 - USD 10000Explore Options
HormonalTherapy : Hormones are often necessary for cancer cells to proliferate and develop. Hormone treatment breaks that connection.
Cost Start From USD 1000 - USD 5000Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.

Kuala Lumpur, Malaysia
In Kuala Lumpur, Malaysia, ParkCity Medical Centre is a 300-bed, cutting-edge, interdisciplinary private hospital that provides award-winning private healthcare in an environment of lush vegetation.

Kuala Lumpur, Malaysia
As a tertiary care hospital, Bukit Tinggi Medical Centre (BTMC) is committed to providing high-quality, reasonably priced healthcare.
With a focus on patient care and a team of committed medical professionals and personnel, we want to realize our ambition of becoming Klang's go-to healthcare provider. Orthopedics, neurosurgery, cardiac surgery, obstetrics and gynecology, pediatrics and rehabilitation, aesthetic surgery, and other specialties are all part of our multidisciplinary team approach. Additionally, BTMC has a Health Screening Center that provides a range of health packages to meet the requirements of diverse patient types.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
It is a kind of breast cancer called invasive ductal carcinoma (IDC) that begins in the milk ducts and spreads to the surrounding breast tissue. A non-invasive disorder known as ductal carcinoma in situ (DCIS) occurs when abnormal cells remain inside the milk ducts and have not migrated to neighbouring tissues.
Invasive ductal carcinoma can affect anyone, but it is more commonly diagnosed in post-menopausal women over the age of 50.
About 83% of all occurrences of breast cancer are invasive ductal carcinoma, making it the most prevalent kind.
The lymphatic system, which includes the lymph nodes under the arms, is a potential route of spread for invasive ductal carcinoma. Additionally, it can travel through blood arteries to the liver, lungs, or bones, among other body regions.
Although the treatments are successful in combating invasive ductal carcinoma, they may also result in adverse effects like changes in appetite, nausea, exhaustion, and hair loss.
The length of recovery following therapy for invasive ductal carcinoma varies based on the cancer's type and stage as well as the patient's general health.
It is possible to treat invasive ductal carcinoma, mainly if diagnosed early. The prognosis for invasive ductal carcinoma has dramatically improved over time due to developments in medical technology and available treatments.
The stage of the malignancy, general health, and response to treatment are some factors affecting the survival rate for invasive ductal carcinoma. The likelihood of a successful outcome increases with the timing of cancer diagnosis and treatment.
It is thought that invasive (infiltrating) ductal carcinoma is one of the most aggressive types of breast cancer. If not identified and treated right away, this kind of cancer has the potential to spread swiftly to other body parts.
A form of invasive ductal carcinoma known as triple-negative IDC is devoid of human epidermal growth factor receptor 2 (HER2), progesterone receptors (PR), and estrogen receptors (ER). When compared to other subtypes of breast cancer, this one is frequently more aggressive and challenging to treat. Targeted therapy is making advancements in this field.
Yes, irreparable harm may result from invasive ductal carcinoma (IDC), particularly if the malignancy is not identified and treated correctly. IDC has the potential to spread to distant organs and lymph nodes, causing more serious and reversible harm. Early detection and timely treatment are essential to avoid irreparable harm and increase the likelihood of positive results.
Most hospitals in Malaysia offer the following:
One can go home in 1-2 days after the surgery, and it takes 4-6 weeks to recover and get back to normal activities fully.
Yes, Malaysia provides cutting-edge diagnostic methods for Invasive Ductal Carcinoma (IDC), such as molecular testing, MRI, PET-CT, and digital mammography. Top hospitals offer modern imaging and biopsy methods to ensure precise diagnosis.
Malaysia is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Malaysia's healthcare system accepts patients from abroad and provides excellent IDC treatments at many clinics and hospitals.
Yes, many hospitals in Malaysia offer in-person and online consultations to foreign patients who want a second opinion.You can get support by speaking with a medical tourism facilitator at MediGence to select the best doctor and facility. It provides specialised rehabilitation programs.
Yes, prestigious hospitals in Malaysia offer lumpectomy, a breast-conserving procedure, for IDC. To successfully treat cancer and maintain breast tissue, it is done in conjunction with radiation therapy.